ER-Positive Metastatic Breast Cancer | Oncology Today with Dr Neil Love: Understanding the Current and Future Role of Oral SERDs (Selective Estrogen Receptor Degraders) in the Management of ER-Positive Metastatic Breast Cancer (Companion Faculty Lecture)
Research To Practice | Oncology Videos · Dr. Neil Love
March 11, 202440m 38s
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring a slide presentation and related discussion from Dr Komal Jhaveri, including the following topics:
- Role of ESR1 mutations in sensitivity and resistance to endocrine therapy in patients with ER-positive metastatic breast cancer (0:00)
- Efficacy and safety of oral SERDs in patients with ER-positive metastatic breast cancer (13:26)
- Similarities and differences among available and investigational oral SERDs for ER-positive metastatic breast cancer (24:21)